View Older Stories

Jun 17, 2025 10:40AM Sage Therapeutics (SAGE) PT Lowered to $8.50 at TD Cowen

Jun 17, 2025 09:46AM Sage Therapeutics (SAGE) PT Raised at Truist; 'SAGE Acquisition A Good Outcome For All'

Jun 17, 2025 03:06AM Piper Sandler Downgrades Sage Therapeutics (SAGE) to Neutral

Jun 16, 2025 07:01AM Supernus Pharma (SUPN) to Acquire Sage Therapeutics (SAGE)

Apr 29, 2025 04:08PM SAGE Therapeutics (SAGE) Misses Q1 EPS by 2c

Mar 8, 2025 01:56PM Grabar Law Office Investigates Claims on Behalf of Shareholders of Sage Therapeutics, Inc. (SAGE)

Mar 4, 2025 04:16PM SAGE Therapeutics (SAGE) Announces R&D Leadership Transition

Feb 12, 2025 06:52AM Sage Therapeutics (SAGE) PT Lowered to $12 at H.C. Wainwright

Feb 12, 2025 06:36AM Sage Therapeutics (SAGE) PT Lowered to $8 at Canaccord Genuity

Feb 11, 2025 04:24PM SAGE Therapeutics (SAGE) Misses Q4 EPS by 6c

Jan 30, 2025 06:41AM Sage Therapeutics (SAGE) PT Raised to $9 at Mizuho

Jan 27, 2025 09:21AM Sage Therapeutics (SAGE) Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s (BIIB) Unsolicited Acquisition Proposal

Jan 27, 2025 09:21AM SAGE Therapeutics (SAGE) Explores Strategic Alternatives

Jan 13, 2025 07:42AM SAGE Therapeutics (SAGE) Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen (BIIB) (earlier)

Jan 13, 2025 05:23AM SAGE Therapeutics (SAGE) 30-day option implied volatility above 80

Jan 2, 2025 10:23AM Sage Therapeutics (SAGE) PT Lowered to $9 at Piper Sandler Following Coverage Transfer

Dec 31, 2024 12:50PM Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm

Dec 12, 2024 06:37AM Sage Therapeutics (SAGE) PT Lowered to $6 at Mizuho

Nov 21, 2024 07:54AM Sage Therapeutics (SAGE) PT Lowered to $9 at TD Cowen

Nov 21, 2024 05:23AM RBC Capital Upgrades Sage Therapeutics (SAGE) to Sector Perform

Nov 20, 2024 06:30AM SAGE Therapeutics (SAGE) Reports Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor

Oct 30, 2024 08:17AM Sage Therapeutics (SAGE) PT Lowered to $10 at Mizuho

Oct 30, 2024 08:13AM Sage Therapeutics (SAGE) PT Lowered to $26 at Piper Sandler

Oct 30, 2024 07:49AM Sage Therapeutics (SAGE) PT Lowered to $14 at Scotiabank

Oct 30, 2024 06:42AM Sage Therapeutics (SAGE) PT Lowered to $14 at H.C. Wainwright

Oct 29, 2024 04:10PM SAGE Therapeutics (SAGE) Tops Q3 EPS by 1c

Oct 17, 2024 07:01AM SAGE Therapeutics (SAGE) Announces Strategic Reorganization to Prioritize ZURZUVAE Commercialization and Focus its Development Portfolio

Oct 10, 2024 08:26AM Raymond James Resumes Sage Therapeutics (SAGE) at Market Perform

Oct 9, 2024 11:46AM Scotiabank Reiterates Sector Outperform Rating on Sage Therapeutics (SAGE)

Oct 9, 2024 06:42AM Sage Therapeutics (SAGE) PT Lowered to $9 at Baird

Oct 8, 2024 02:41PM Sage Therapeutics (SAGE) PT Lowered to $9 at Oppenheimer

Oct 8, 2024 06:30AM Sage Therapeutics (SAGE) Announces Topline Results from the Phase 2 LIGHTWAVE Study of Dalzanemdor

Oct 4, 2024 05:09AM RBC Downgrades Sage (SAGE) to Underperform, 'Too Much Riding On Dalza Huntington's Readout Our Analysis Shows Is High Risk'

Sep 26, 2024 07:01AM SAGE Therapeutics (SAGE) Announces Discontinuation of the Collaboration with Biogen on the SAGE-324 Program

Sep 17, 2024 06:37AM SAGE Therapeutics (SAGE) Files Mixed Shelf

Aug 14, 2024 05:27AM Sage Therapeutics (SAGE) PT Lowered to $13 at Truist Securities

Aug 13, 2024 04:57AM Increasing unusual call option volume: UMC IAU SAGE ABEV K DLO LUMN GENI ACI

Aug 1, 2024 07:46AM Sage Therapeutics (SAGE) PT Lowered to $52 at Piper Sandler

Aug 1, 2024 06:56AM Sage Therapeutics (SAGE) PT Lowered to $12 at Mizuho

Aug 1, 2024 06:40AM Sage Therapeutics (SAGE) PT Lowered to $15 at Stifel

Jul 31, 2024 04:18PM SAGE Therapeutics (SAGE) Misses Q2 EPS by 6c

Jul 30, 2024 05:29AM TD Cowen Downgrades Sage Therapeutics (SAGE) to Hold

Jul 25, 2024 07:17AM Sage Therapeutics (SAGE) PT Lowered to $17 at Scotiabank

Jul 25, 2024 06:59AM Sage Therapeutics (SAGE) PT Lowered to $13 at Baird

Jul 25, 2024 06:54AM Sage Therapeutics (SAGE) PT Lowered to $13 at Mizuho

Jul 25, 2024 03:08AM JPMorgan Downgrades Sage Therapeutics (SAGE) to Neutral

Jul 24, 2024 08:15AM Sage Therapeutics stock sinks after drug study failed

Jul 24, 2024 07:43AM SAGE Therapeutics (SAGE) Falls 24% After Phase 2 KINETIC 2 Study of SAGE-324 Fails

Jul 24, 2024 06:32AM SAGE Therapeutics (SAGE) and Biogen (BIIB) Report Topline Results from Phase 2 KINETIC 2 Study of SAGE-324

Jul 19, 2024 06:36AM Sage Therapeutics (SAGE) PT Lowered to $16 at Mizuho

View Older Stories